Fast Facts
Multiple myeloma is a type of blood cancer that affects plasma cells, which are a type of white blood cell responsible for producing antibodies.1
The average lifetime risk of getting multiple myeloma is approximately 1 in 103 for men and about 1 in 131 for women in the United States.2
Staying informed about multiple myeloma is crucial in providing the highest quality care to our patients. Multiple myeloma is a complex and often challenging disease, and our role in managing it requires a comprehensive understanding of its presentation, diagnosis, and treatment. By prioritizing our education and understanding of multiple myeloma, we demonstrate our commitment to excellence in patient care. Our informed approach not only improves clinical outcomes, but also fosters a trusting and supportive relationship with our patients. Informed and compassionate care is the cornerstone of our practice, and it is through knowledge that we can truly make a difference in the lives of those we serve.
Donna D. Catamero, ANP‑BC, OCN, CCRC
References: 1. Multiple myeloma. Mayo Clinic. Updated July 30, 2024. Accessed August 2, 2024. https://www.mayoclinic.org/diseases-conditions/multiple-myeloma/symptoms-causes/syc-20353378 2. Key Statistics About Multiple Myeloma. Updated January 19, 2024. Accessed August 2, 2024. https://www.cancer.org/cancer/types/multiple-myeloma/about/key-statistics.html 3. Cancer Stat Facts: Myeloma. National Cancer Institute Surveillance, Epidemiology, and End Results Program. Accessed August 2, 2024. https://seer.cancer.gov/statfacts/html/mulmy.html